Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
暂无分享,去创建一个
Antonio Coluccia | Marianna Bufano | Marion Laudette | Jean-Paul Blondeau | Frank Lezoualc’h | Marianna Nalli | Romano Silvestri | Andrea Brancale | A. Coluccia | A. Brancale | R. Silvestri | F. Lezoualc’h | Marianna Bufano | M. Nalli | M. Laudette | J. Blondeau | Marion Laudette | Antonio Coluccia
[1] Ivet Bahar,et al. Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe Molecules , 2012, Journal of Chemical Theory and Computation.
[2] A. Wittinghofer,et al. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state , 2006, Nature.
[3] Feng Zhao,et al. Protein threading using context-specific alignment potential , 2013, Bioinform..
[4] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[5] Alexander D. MacKerell,et al. Pharmacophore Modeling Using Site-Identification by Ligand Competitive Saturation (SILCS) with Multiple Probe Molecules , 2015, J. Chem. Inf. Model..
[6] Rajeevan Selvaratnam,et al. The Auto-Inhibitory Role of the EPAC Hinge Helix as Mapped by NMR , 2012, PloS one.
[7] Heather A. Carlson,et al. Parameter Choice Matters: Validating Probe Parameters for Use in Mixed-Solvent Simulations , 2014, J. Chem. Inf. Model..
[8] T. Eschenhagen,et al. β-Adrenergic stimulation and myocardial function in the failing heart , 2009, Heart Failure Reviews.
[9] Xiaodong Cheng,et al. Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development. , 2018, Physiological reviews.
[10] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[11] D. Bers. Calcium cycling and signaling in cardiac myocytes. , 2008, Annual review of physiology.
[12] Imran Siddiqi,et al. Solvated Interaction Energy (SIE) for Scoring Protein-Ligand Binding Affinities, 1. Exploring the Parameter Space , 2007, J. Chem. Inf. Model..
[13] J. Beavo,et al. Cyclic nucleotide research — still expanding after half a century , 2002, Nature Reviews Molecular Cell Biology.
[14] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[15] Rajeevan Selvaratnam,et al. Role of Dynamics in the Autoinhibition and Activation of the Exchange Protein Directly Activated by Cyclic AMP (EPAC)* , 2011, The Journal of Biological Chemistry.
[16] M. Bouvet,et al. The Epac1 Protein: Pharmacological Modulators, Cardiac Signalosome and Pathophysiology , 2019, Cells.
[17] H. Berendsen,et al. Essential dynamics of proteins , 1993, Proteins.
[18] H J Berendsen,et al. An efficient method for sampling the essential subspace of proteins. , 1996, Journal of biomolecular structure & dynamics.
[19] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[20] Z. Rao,et al. Structural study of the Cdc25 domain from Ral-specific guanine-nucleotide exchange factor RalGPS1a , 2011, Protein & Cell.
[21] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[22] F. Dekker,et al. Exchange Protein Directly Activated by cAMP (epac): A Multidomain cAMP Mediator in the Regulation of Diverse Biological Functions , 2013, Pharmacological Reviews.
[23] Ying Liu,et al. Evol and ProDy for bridging protein sequence evolution and structural dynamics , 2014, Bioinform..
[24] S. J. Campbell,et al. Ligand binding: functional site location, similarity and docking. , 2003, Current opinion in structural biology.
[25] Jian Peng,et al. Template-based protein structure modeling using the RaptorX web server , 2012, Nature Protocols.
[26] J. Westley,et al. Enzyme Inhibition in Open Systems , 1996, The Journal of Biological Chemistry.
[27] Thomas D. Goddard,et al. Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions. , 2010, Journal of structural biology.
[28] J A McCammon,et al. Analysis of a 10-ns molecular dynamics simulation of mouse acetylcholinesterase. , 2001, Biophysical journal.
[29] José Mario Martínez,et al. PACKMOL: A package for building initial configurations for molecular dynamics simulations , 2009, J. Comput. Chem..
[30] Xiaodong Cheng,et al. Interplay between exchange protein directly activated by cAMP (Epac) and microtubule cytoskeleton. , 2005, Molecular bioSystems.
[31] Thomas Stützle,et al. Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS , 2009, J. Chem. Inf. Model..
[32] A. Wittinghofer,et al. Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs* , 2000, The Journal of Biological Chemistry.
[33] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[34] A. Coluccia,et al. Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress. , 2019, Cardiovascular research.
[35] T. Shibasaki,et al. Critical role of the N‐terminal cyclic AMP‐binding domain of Epac2 in its subcellular localization and function , 2009, Journal of cellular physiology.
[36] H. Carlson,et al. Driving Structure-Based Drug Discovery through Cosolvent Molecular Dynamics. , 2016, Journal of medicinal chemistry.
[37] Marwen Naïm,et al. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex. , 2008, Journal of molecular biology.
[38] Yong Zhou,et al. Epac1 interacts with importin β1 and controls neurite outgrowth independently of cAMP and Rap1 , 2016, Scientific Reports.
[39] I. Bahar,et al. Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe Molecules. , 2013, Journal of chemical theory and computation.
[40] Sumit Kumar,et al. Effect of acceptor heteroatoms on π-hydrogen bonding interactions: a study of indole···thiophene heterodimer in a supersonic jet. , 2012, The Journal of chemical physics.
[41] J. Janin,et al. A dissection of specific and non-specific protein-protein interfaces. , 2004, Journal of molecular biology.
[42] Karen N. Allen,et al. An Experimental Approach to Mapping the Binding Surfaces of Crystalline Proteins , 1996 .
[43] Daniel R Roe,et al. PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. , 2013, Journal of chemical theory and computation.
[44] Giuseppe Melacini,et al. Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states. , 2007, Journal of the American Chemical Society.
[45] Susan S. Taylor,et al. The cAMP binding domain: an ancient signaling module. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Andrew McCammon,et al. Identification of Protein–Ligand Binding Sites by the Level-Set Variational Implicit-Solvent Approach , 2015, Journal of chemical theory and computation.
[47] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[48] Richard H. Henchman,et al. Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation. , 2002, Journal of the American Chemical Society.
[49] F. Lezoualc’h,et al. Identification of a Tetrahydroquinoline Analog as a Pharmacological Inhibitor of the cAMP-binding Protein Epac* , 2012, The Journal of Biological Chemistry.
[50] J. Bos,et al. Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B , 2008, Nature.
[51] Ivet Bahar,et al. ProDy: Protein Dynamics Inferred from Theory and Experiments , 2011, Bioinform..
[52] P. Kollman,et al. Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.
[53] Brian O. Smith,et al. The cAMP sensors, EPAC1 and EPAC2, display distinct subcellular distributions despite sharing a common nuclear pore localisation signal , 2015, Cellular signalling.
[54] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[55] Z. Xiang,et al. On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.
[56] Shigenori Tanaka,et al. Cosolvent-Based Molecular Dynamics for Ensemble Docking: Practical Method for Generating Druggable Protein Conformations , 2017, J. Chem. Inf. Model..
[57] Alexander D. MacKerell,et al. Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5. , 2015, Bioorganic & medicinal chemistry letters.
[58] A. Wittinghofer,et al. Structure and regulation of the cAMP-binding domains of Epac2 , 2003, Nature Structural Biology.
[59] Christopher L. McClendon,et al. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.
[60] F. Lezoualc’h,et al. The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1). , 2013, Biochemical and Biophysical Research Communications - BBRC.
[61] J. Mccammon,et al. Allosteric Inhibition of Epac , 2014, The Journal of Biological Chemistry.
[62] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.